A dipyrido [2,3-b:3',2'-f]azepine analog of the HIV-1 reverse transcriptase inhibitor nevirapine

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 16, 1998, Pages 2169-2172

  Dyatkin, Alexey B ^a   Brickwood, Janice R ^b   Proudfoot, John R ^b  

^a Department of Chemical Development ^*  (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIPYRIDO[2,3 B:3',2' F]AZEPINE DERIVATIVE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEVIRAPINE; NEVIRAPINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; STRUCTURE ACTIVITY RELATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032544175     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00369-2     Document Type: Article

References (16)

1. 1. Current address: The R.W. Johnson Pharmaceutical Research Institute, Welsh and McKean Roads, Spring House, PA 19477-0776.
2. 2. Merluzzi, V. J.; Hargrave, K. D.; Labadia, M.; Grozinger, K.; Skoog, M.; Wu, J. C.; Shih, C.-K.; Eckner, K.; Hattox, S.; Adams, J.; Rosenthal, A. S.; Faanes, R.; Eckner, R. J.; Koup, R. A.; Sullivan, J. L. Science 1990, 250, 1411.
3. 3. (a) Margrave, K. D.; Proudfoot, J. R.; Grozinger, K. G.; Cullen, E.; Kapadia, S. R.; Patel, U. R.; Fuchs, V. U.; Mauldin, S. C.; Vitous, J.; Behnke, M. L.; Klunder, J. M.; Pal, K.; Skiles, J. W.; McNeil, D. W.; Rose, J. M.; Chow, G. C.; Skoog, M. T.; Wu, J. C.; Schmidt, G.; Engel, W. W.; Eberlein, W. G.; Saboe, T. D.; Campbell, S. J.; Rosenthal, A. S.; Adams, J. J. Med. Chem. 1991, 34, 2231.
4. (b) Proudfoot, J. R.; Patel, U. R.; Campbell, S. J. J. Org. Chem. 1993, 58, 6996.
5. (c) Proudfoot, J. R.; Patel, U. R.; Kapadia, S. R.; Hargrave, K. D. J. Med. Chem. 1995, 38, 1406.
6. (d) Proudfoot, J. R. Bioorg. Med. Chem. Lett. 1995, 5, 163.
7. (e) Klunder, J. M.; Hargrave, K. D.; West, M.; Cullen, E.; Pal, K.; Behnke, M. L.; Kapadia, S. R.; McNeil, D. W.; Wu, J. C.; Chow, G. C.; Adams, J. J. Med. Chem. 1992, 35, 1887.
8. (f) Bellarosa, D.; Antonelli, G.; Bambacioni, F.; Gianotti, D.; Viti, G.; Nannicini, R.; Giachetti, A.; Dianzani, F.; Witvrouw, M.; Pauwels, R.; Desmyter, J.; De Clercq, E. Antiviral Research, 1996, 30, 109.
9. 4. Terret, N. K.; Bojanic, D.; Merson, J. R.; Stephenson, P. T.; Bioorg. Med. Chem. Lett. 1992, 2, 1745.
10. 5. Estel, L.; Marsais, F.; Queguiner, G. J. Org. Chem. 1988, 53, 2740.
11. 6. (a) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 4467.
12. (b) Sakamoto, T.; Shiraiwa, M.; Kondo, Y.; Yamanaka, H. Synthesis, 1983, 312.
13. 7. Warner, B. P.; Buchwald, S. L. J. Org. Chem. 1994, 59, 5822.
14. 8. Lipshutz, B. H.; Keil, R.; Barton, J. C. Tetrahedron Lett. 1992, 33, 5861.
15. 9. For details of the enzyme assay see ref 3a.
16. 10. Ren, J.; Esnouf, R.; Garman, E.; Somers, D.; Ross, C.; Kirby, I.; Keeling, J.; Darby, G.; Jones, Y.; Stuart, D.; Stammers, D. Structural Biology 1995, 2, 293.